Skip to main content

Pfizer COVID-19 vaccine just 42% effective against infection amid delta spread, preprint suggests

Early findings posted ahead of rigorous peer review suggested the Pfizer COVID-19 vaccine declined to 42% effectiveness against infection amid sweeping spread of the delta variant, with the Moderna vaccine declining to 76%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.